Report Detail

Request for Sample of this report

Chemical & Material Global Azilsartan Medoxomil API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4512415
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

Azilsartan medoxomil (trade name Edarb) is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone. It is indicated for the treatment of hypertension to lower blood pressure which reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Azilsartan medoxomil may be used either alone or in combination with other antihypertensive agents such as chlorthalidone (CLD). As an ARB, azilsartan medoxomil selectively inhibits angiotensin II from binding to the angiotensin II type-1 receptor (AT1). This receptor inhibition provides the antihypertensive activity of azilsartan medoxomil because it blocks the pressor effects of angiotensin II. Azilsartan medoxomil is a prodrug of azilsartan. It is hydrolyzed to the active moiety, azilsartan, in the gastrointestinal (GI) tract during the absorption phase.
According to our (Global Info Research) latest study, the global Azilsartan Medoxomil API market size was valued at US$ 19.2 million in 2023 and is forecast to a readjusted size of USD 66 million by 2030 with a CAGR of 19.5% during review period.
Main manufacturers of global azilsartan medoxomil API market are Takeda, Metrochem API and Jubilant Pharma. Takeda and Metrochem API are the top 2 players and accounts for over 40% of global market share in total. Geographically speaking, USA is the largest market and covers about 30% of total market share, followed by Europe with 20%. In terms of application, 40 mg Tablets holds an important market share of over 50%.
This report is a detailed and comprehensive analysis for global Azilsartan Medoxomil API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Azilsartan Medoxomil API market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2019-2030
Global Azilsartan Medoxomil API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2019-2030
Global Azilsartan Medoxomil API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2019-2030
Global Azilsartan Medoxomil API market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Azilsartan Medoxomil API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Azilsartan Medoxomil API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, Lupin, Acura Labs, Metrochem API, Jubilant Pharma, Zhejiang Hongyuan, Honour Lab, HEC Pharm, Enomark, CTX Life Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Azilsartan Medoxomil API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.99
Others
Market segment by Application
20 mg Tablets
40 mg Tablets
80 mg Tablets
Major players covered
Takeda
Lupin
Acura Labs
Metrochem API
Jubilant Pharma
Zhejiang Hongyuan
Honour Lab
HEC Pharm
Enomark
CTX Life Sciences
Zhejiang Tianyu
Zhuhai Rundu
Valiant Co
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Azilsartan Medoxomil API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Azilsartan Medoxomil API, with price, sales quantity, revenue, and global market share of Azilsartan Medoxomil API from 2019 to 2024.
Chapter 3, the Azilsartan Medoxomil API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Azilsartan Medoxomil API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Azilsartan Medoxomil API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Azilsartan Medoxomil API.
Chapter 14 and 15, to describe Azilsartan Medoxomil API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Azilsartan Medoxomil API Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 0.99
    • 1.3.3 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Azilsartan Medoxomil API Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 20 mg Tablets
    • 1.4.3 40 mg Tablets
    • 1.4.4 80 mg Tablets
  • 1.5 Global Azilsartan Medoxomil API Market Size & Forecast
    • 1.5.1 Global Azilsartan Medoxomil API Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Azilsartan Medoxomil API Sales Quantity (2019-2030)
    • 1.5.3 Global Azilsartan Medoxomil API Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Takeda
    • 2.1.1 Takeda Details
    • 2.1.2 Takeda Major Business
    • 2.1.3 Takeda Azilsartan Medoxomil API Product and Services
    • 2.1.4 Takeda Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Takeda Recent Developments/Updates
  • 2.2 Lupin
    • 2.2.1 Lupin Details
    • 2.2.2 Lupin Major Business
    • 2.2.3 Lupin Azilsartan Medoxomil API Product and Services
    • 2.2.4 Lupin Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Lupin Recent Developments/Updates
  • 2.3 Acura Labs
    • 2.3.1 Acura Labs Details
    • 2.3.2 Acura Labs Major Business
    • 2.3.3 Acura Labs Azilsartan Medoxomil API Product and Services
    • 2.3.4 Acura Labs Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Acura Labs Recent Developments/Updates
  • 2.4 Metrochem API
    • 2.4.1 Metrochem API Details
    • 2.4.2 Metrochem API Major Business
    • 2.4.3 Metrochem API Azilsartan Medoxomil API Product and Services
    • 2.4.4 Metrochem API Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Metrochem API Recent Developments/Updates
  • 2.5 Jubilant Pharma
    • 2.5.1 Jubilant Pharma Details
    • 2.5.2 Jubilant Pharma Major Business
    • 2.5.3 Jubilant Pharma Azilsartan Medoxomil API Product and Services
    • 2.5.4 Jubilant Pharma Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Jubilant Pharma Recent Developments/Updates
  • 2.6 Zhejiang Hongyuan
    • 2.6.1 Zhejiang Hongyuan Details
    • 2.6.2 Zhejiang Hongyuan Major Business
    • 2.6.3 Zhejiang Hongyuan Azilsartan Medoxomil API Product and Services
    • 2.6.4 Zhejiang Hongyuan Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Zhejiang Hongyuan Recent Developments/Updates
  • 2.7 Honour Lab
    • 2.7.1 Honour Lab Details
    • 2.7.2 Honour Lab Major Business
    • 2.7.3 Honour Lab Azilsartan Medoxomil API Product and Services
    • 2.7.4 Honour Lab Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Honour Lab Recent Developments/Updates
  • 2.8 HEC Pharm
    • 2.8.1 HEC Pharm Details
    • 2.8.2 HEC Pharm Major Business
    • 2.8.3 HEC Pharm Azilsartan Medoxomil API Product and Services
    • 2.8.4 HEC Pharm Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 HEC Pharm Recent Developments/Updates
  • 2.9 Enomark
    • 2.9.1 Enomark Details
    • 2.9.2 Enomark Major Business
    • 2.9.3 Enomark Azilsartan Medoxomil API Product and Services
    • 2.9.4 Enomark Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Enomark Recent Developments/Updates
  • 2.10 CTX Life Sciences
    • 2.10.1 CTX Life Sciences Details
    • 2.10.2 CTX Life Sciences Major Business
    • 2.10.3 CTX Life Sciences Azilsartan Medoxomil API Product and Services
    • 2.10.4 CTX Life Sciences Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 CTX Life Sciences Recent Developments/Updates
  • 2.11 Zhejiang Tianyu
    • 2.11.1 Zhejiang Tianyu Details
    • 2.11.2 Zhejiang Tianyu Major Business
    • 2.11.3 Zhejiang Tianyu Azilsartan Medoxomil API Product and Services
    • 2.11.4 Zhejiang Tianyu Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Zhejiang Tianyu Recent Developments/Updates
  • 2.12 Zhuhai Rundu
    • 2.12.1 Zhuhai Rundu Details
    • 2.12.2 Zhuhai Rundu Major Business
    • 2.12.3 Zhuhai Rundu Azilsartan Medoxomil API Product and Services
    • 2.12.4 Zhuhai Rundu Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Zhuhai Rundu Recent Developments/Updates
  • 2.13 Valiant Co
    • 2.13.1 Valiant Co Details
    • 2.13.2 Valiant Co Major Business
    • 2.13.3 Valiant Co Azilsartan Medoxomil API Product and Services
    • 2.13.4 Valiant Co Azilsartan Medoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Valiant Co Recent Developments/Updates

3 Competitive Environment: Azilsartan Medoxomil API by Manufacturer

  • 3.1 Global Azilsartan Medoxomil API Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Azilsartan Medoxomil API Revenue by Manufacturer (2019-2024)
  • 3.3 Global Azilsartan Medoxomil API Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Azilsartan Medoxomil API by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Azilsartan Medoxomil API Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Azilsartan Medoxomil API Manufacturer Market Share in 2023
  • 3.5 Azilsartan Medoxomil API Market: Overall Company Footprint Analysis
    • 3.5.1 Azilsartan Medoxomil API Market: Region Footprint
    • 3.5.2 Azilsartan Medoxomil API Market: Company Product Type Footprint
    • 3.5.3 Azilsartan Medoxomil API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Azilsartan Medoxomil API Market Size by Region
    • 4.1.1 Global Azilsartan Medoxomil API Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Azilsartan Medoxomil API Consumption Value by Region (2019-2030)
    • 4.1.3 Global Azilsartan Medoxomil API Average Price by Region (2019-2030)
  • 4.2 North America Azilsartan Medoxomil API Consumption Value (2019-2030)
  • 4.3 Europe Azilsartan Medoxomil API Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Azilsartan Medoxomil API Consumption Value (2019-2030)
  • 4.5 South America Azilsartan Medoxomil API Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Azilsartan Medoxomil API Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Azilsartan Medoxomil API Sales Quantity by Type (2019-2030)
  • 5.2 Global Azilsartan Medoxomil API Consumption Value by Type (2019-2030)
  • 5.3 Global Azilsartan Medoxomil API Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Azilsartan Medoxomil API Sales Quantity by Application (2019-2030)
  • 6.2 Global Azilsartan Medoxomil API Consumption Value by Application (2019-2030)
  • 6.3 Global Azilsartan Medoxomil API Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Azilsartan Medoxomil API Sales Quantity by Type (2019-2030)
  • 7.2 North America Azilsartan Medoxomil API Sales Quantity by Application (2019-2030)
  • 7.3 North America Azilsartan Medoxomil API Market Size by Country
    • 7.3.1 North America Azilsartan Medoxomil API Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Azilsartan Medoxomil API Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Azilsartan Medoxomil API Sales Quantity by Type (2019-2030)
  • 8.2 Europe Azilsartan Medoxomil API Sales Quantity by Application (2019-2030)
  • 8.3 Europe Azilsartan Medoxomil API Market Size by Country
    • 8.3.1 Europe Azilsartan Medoxomil API Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Azilsartan Medoxomil API Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Azilsartan Medoxomil API Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Azilsartan Medoxomil API Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Azilsartan Medoxomil API Market Size by Region
    • 9.3.1 Asia-Pacific Azilsartan Medoxomil API Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Azilsartan Medoxomil API Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Azilsartan Medoxomil API Sales Quantity by Type (2019-2030)
  • 10.2 South America Azilsartan Medoxomil API Sales Quantity by Application (2019-2030)
  • 10.3 South America Azilsartan Medoxomil API Market Size by Country
    • 10.3.1 South America Azilsartan Medoxomil API Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Azilsartan Medoxomil API Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Azilsartan Medoxomil API Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Azilsartan Medoxomil API Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Azilsartan Medoxomil API Market Size by Country
    • 11.3.1 Middle East & Africa Azilsartan Medoxomil API Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Azilsartan Medoxomil API Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Azilsartan Medoxomil API Market Drivers
  • 12.2 Azilsartan Medoxomil API Market Restraints
  • 12.3 Azilsartan Medoxomil API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Azilsartan Medoxomil API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Azilsartan Medoxomil API
  • 13.3 Azilsartan Medoxomil API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Azilsartan Medoxomil API Typical Distributors
  • 14.3 Azilsartan Medoxomil API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Azilsartan Medoxomil API. Industry analysis & Market Report on Azilsartan Medoxomil API is a syndicated market report, published as Global Azilsartan Medoxomil API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Azilsartan Medoxomil API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo